Ani Pharmaceuticals Inc (ANIP)

SG&A Expenses

$324.76M

TTM · Period ending: · USD

ANIP logo

ANIP SG&A Expenses

Latest reported$324.76M
ANIP TTM SG&A Expenses ($1.68M → $324.76M)
High-resolution chart · PNG

ANIP sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ani Pharmaceuticals Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
324,762,000
314,872,000
317,745,000
304,674,000
307,093,000
278,143,000
249,636,000
224,379,000
187,311,000
173,250,000
161,697,000
150,423,000
138,497,000
131,695,000
124,044,000
121,562,000
108,662,000
95,524,000
84,294,000
67,953,000
66,497,000
68,890,000
64,986,000
64,635,000
63,267,000
56,242,000
55,843,000
55,205,000
52,617,000
48,391,000
44,063,000
39,572,000
35,825,000
33,243,000
31,580,000
30,064,000
28,970,000
29,218,000
27,829,000
25,915,000
24,386,000
22,309,000
21,156,000
20,443,000
19,101,000
18,983,000
17,935,000
16,620,000
16,124,216
17,935,342
16,181,456
15,656,268
13,641,916
8,346,785
8,229,523
7,051,348
7,179,752
7,219,860
6,981,565
6,625,419
6,484,568
6,035,665
6,209,110
6,770,966
6,742,605
6,411,361
5,673,561
5,348,103
5,280,863
5,665,063
5,961,354
5,477,067
5,065,445
4,796,571
4,463,465
6,467,098
5,650,456
5,654,786
7,025,418
4,752,103
5,246,517
4,693,079
3,050,555
3,049,217
2,832,549
2,800,619
3,080,135
2,910,359
2,903,134
2,824,808
2,327,090
2,049,124
1,981,855
1,808,788
1,765,624
1,979,952
2,286,609
2,292,730
2,298,659
2,337,398
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.